← Leaderboards
Zhao-Jun Liu
University Of Miami School Of Medicine
$1,776,809
Attributed
$4,493,549
Total exposure
3
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.3M · FY2019–24$2M$1.5M$1M$500K$0
'19
'20
'21
'22
'23
'24
Funding mix
By agency
NIH$4,493,549 · 3
By mechanism
R01$2,819,793 · 1
R33$1,140,505 · 1
R61$533,251 · 1
Top collaborators
- Omaida C Velazquez8 shared
- Sylvia Daunert4 shared
Most similar at University Of Miami School Of Medicine
Same institution · by research overlap
- Roberta Marques Lassance-Soares$1,390,269
- Marjana Tomic-Canic$10,626,647
- Jill Tincher$881,432
- Herman S Cheung$1,214,855
- Gianluca D'ippolito$406,810
Others in their field
Other Emerging Leaders on “Non-Healing Wounds”
- Shruti Naik · New York University School Of Medicine$4,593,171
- Mitchel R Stacy · Yale University$3,900,338
- Stephanie Deshayes · Tempo Therapeutics, Inc.$2,549,496
- Junwang Xu · University Of Colorado Denver$2,311,851
- Evi X. Stavrou · Louis Stokes Cleveland Va Medical Center$1,951,348
- Lindsay Robyn Kalan · University Of Wisconsin-Madison$1,933,171
Research focus
Non-Healing WoundsPathologicLimb StructureMuscle CellsNeovascularizationLimb AmputationHealth Care CostsCellsHealingGenerationsHigh RiskHomingIsolated Limb PerfusionLigandsClinically RelevantBlood VesselsCell Adhesion MoleculesCell CommunicationAmputationEndothelial CellsE-SelectinGangreneAngiogenesisPeripheral Arterial Disease
Grant awards (8)
Novel Gene Therapy for Critical Limb Ischemia and Limb Salvage in Vascular Occlusive Disease$526,505
R33 · FY2024 · HL
Novel Gene Therapy for Critical Limb Ischemia and Limb Salvage in Vascular Occlusive Disease$76,750
R33 · FY2024 · HL
Novel Gene Therapy for Critical Limb Ischemia and Limb Salvage in Vascular Occlusive Disease$537,250
R33 · FY2023 · HL
Targeted cell delivery for treatment of non-healing wounds and gangrene$731,645
R01 · FY2022 · HL · contact PI
Novel Gene Therapy for Critical Limb Ischemia and Limb Salvage in Vascular Occlusive Disease$533,251
R61 · FY2022 · HL
Targeted cell delivery for treatment of non-healing wounds and gangrene$731,645
R01 · FY2021 · HL · contact PI
Targeted cell delivery for treatment of non-healing wounds and gangrene$739,013
R01 · FY2020 · HL · contact PI
Targeted cell delivery for treatment of non-healing wounds and gangrene$617,490
R01 · FY2019 · HL · contact PI